People are being diagnosed with chlamydia and gonorrhea at a higher rate than ever before, according to the Centers for Disease Control and Prevention (CDC).
The U.S. Preventive Services Task Force (USPSTF) recently reviewed the latest evidence on screening for chlamydia and gonorrhea and ultimately issued an update to their 2014 recommendation.
The new recommendation, published in JAMA, deems screening for chlamydia and gonorrhea "critical because these STIs often do not cause symptoms, which makes them harder to detect," according to USPSTF vice-chair Michael Barry, MD.
Are you seeing a rise in STI cases in your practice?
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.